Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by ggh2257on Nov 30, 2016 11:46pm
204 Views
Post# 25538197

RE:The Bloom Burton Report (other assumptions)

RE:The Bloom Burton Report (other assumptions)Agree with you Francois, this is a very bad piece of litterature this B&B report.

I did post the US patent recently (US patent US2016023983), I realized my post was badly formated!

I'm a chemist, and saying that PBI-4050 is simply an analogue of PhenylAcetic acid is irrelavent. Aspirin is as simple and we (well Bayer) are stil selling up to 120 billions 300mg pills a year.

The human body couldn't care less how complex a molecule is! As long as it has a beneficial effect, it's great. PBI-4050 has been filed for patent in 2014 and it's covering a list of possible analogues on R and Q positions. As you know the filing of patents is not to explain the MoA, it's to make sure you are not going to work for years on something that has been discovered/used already in the past!

They way PL responded to his question, on the AD I think he is well aware about his goal.

And btw Sky, companies does not announced or advertized received patents. This is all done in the background quietly

We should have a great summer! GLTA




Bullboard Posts